Musculoskeletal Diseases |
| Recruiting | 2b | 178 | Europe, RoW | ALLOB, placebo | Bone Therapeutics S.A, ICON plc | Tibial Fracture | 07/22 | 03/24 | | |
ACTRN12613000680763: A randomised controlled trial evaluating the use of Motivational Interviewing compared to usual care to increase physical activity in people living in the community after a hip fracture |
|
|
| Not yet recruiting | 2 | 24 | | | Dr Paul O'Halloran from La Trobe University , La Trobe University
Faculty of Health Sciences
Physical Activity and Rehabilitation group | hip fracture rehabilitation - increasing activity, hip fracture rehabilitation - quality of life , hip fracture rehabilitation - mental health | | | | |
| Not yet recruiting | 2 | 40 | | | The Alfred, Transport Accident Commission | Multi-system trauma with femoral shaft fracture | | | | |
| Not yet recruiting | 2 | 40 | | | Monash University, Monash University Department of Epidemiology and Preventive Medicine | Tibial shaft fracture, Femoral shaft fracture | | | | |
ACTRN12610000848000: Does the perioperative use of Gabapentin reduce analgesia requirements in patients having delayed open reduction and internal fixation of forearm or ankle fractures? |
|
|
| Not yet recruiting | 2 | 50 | | | Iain Salkield, Princess Alexandra Hospital | Peri-operative pain, Forearm and ankle fractures | | | | |
ACTRN12607000404426: Does a Stretching Regime Decrease Posterior Shoulder Tightness in People with Subacromial Impingement Syndrome? |
|
|
| Not yet recruiting | 2 | 60 | | | Queensland Health, Queensland Health | Subacromial Impingement Syndrome | | | | |
ACTRN12621000789864p: The effect of dexamethasone on duration of analgesia from fascia iliaca compartment blocks in emergency department patients with hip fractures |
|
|
| Not yet recruiting | 2 | 72 | | | Bashir Chakar, Green Light Institute for Emergency Care | Hip fracture; Fascia Iliaca Compartment Block | | | | |
ACTRN12622000723785: Topical application of Cannabis oils and substitutes for the relief of osteoarthritic pain |
|
|
| Not yet recruiting | 2 | 72 | | | Westmead Hospital, Westmead Research Foundation | osteoarthritis | | | | |
ACTRN12613001074785: Using oral broad-spectrum antibiotics as an adjuvant therapy in conservative management of lumbar disc hernia; a clinical trial |
|
|
| Not yet recruiting | 2 | 90 | | | Daniel F Fouladi, Daniel F Fouladi | Lumbar disc hernia | | | | |
ACTRN12622000120774: Is ZTL-106 effective in treating patients with chronic pain that resulted from a musculoskeletal injury? |
|
|
| Not yet recruiting | 2 | 114 | | | Levin Health Ltd, Levin Health Ltd | chronic non-cancer pain, musculoskeletal injury | | | | |
ACTRN12606000219583: Introducing CT scans into a clinical pathway to manage “clinical fractured scaphoid” |
|
|
| Recruiting | 2 | 100 | | | Ballarat Health Services (BHS), Ballarat Health Services, National Institute of Clinical Studies | Clinical Scaphoid fracture. Ie, 'anatomical snuffbox' tenderness with normal plain x-rays | | | | |
2021-003315-25: Botulinum toxin and degenerative rotator cuff tendinopathies: a randomized trial »DEROTOX (DEgenerative ROtator cuff disease and botulinum TOXin) Toxine botulique et tendinopathies dégénératives de la coiffe des rotateurs : un essai randomisé » DEROTOX (DEgenerative ROtator cuff disease and botulinum TOXin) |
|
|
| Ongoing | 2 | 60 | Europe | XEOMIN, Powder for solution for injection, XEOMIN 100 units powder for solution for injection | , ASSISTANCE PUBLIQUE – HÔPITAUX DE PARIS - Direction de la Recherche Clinique et de l’Innovation | Degenerative tendinopathies of the rotator cuff Tendinopathies dégénératives de la coiffe des rotateurs, Diseases of the tendons of the patella of the shoulder Maladies des tendons de la rotule de l'épaule, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
ACTRN12614001016628: The Effects Of Intraarticular Platelet Rich Plasma versus Steroid Injection In Meniscal Injuries- A Randomized Controlled Trial |
|
|
| Recruiting | 2 | 30 | | | Combined military hospital, Panoaqil cantt, Combined Military Hospital, Panoaqil | Meniscal injuries | | | | |
| Recruiting | 2 | 250 | | | Nepean Hospital (Nepean Blue Mountain Local Health District), Orthopaedic Department, Nepean Hospital | Intra capsular neck of femur fractures | | | | |
ACTRN12621000789864: The effect of dexamethasone on duration of analgesia from fascia iliaca compartment blocks in emergency department patients with hip fractures |
|
|
| Recruiting | 2 | 72 | | | Bashir Chakar, Green Light Institute for Emergency Care | Hip fracture, Fascia Iliaca Compartment Block | | | | |
ACTRN12621000654853: A Double-Blind, RandoMised, Placebo-Controlled Study to Assess the
Efficacy and Safety of oRal deliVery of sodium Pentosan Polysulfate (PPS)
compared to placebo in participants with symptomatic kneE osteoarthritis
(OA) and dysLipidemia (MaRVeL Study) |
|
|
| Recruiting | 2 | 92 | | | The University of Sydney, Arthropharm Pty Ltd | Musculoskeletal Knee Osteoarthritis | | | | |
2004-004496-10: A Phase 2a double blind, randomised, placebo controlled, two dose study to determine the effect of orally administered methylnaltrexone (MNTX) in preventing post-operative opiate induced constipation in patients undergoing elective orthopaedic surgery |
|
|
| Ongoing | 2 | 36 | Europe | Coated Methylnaltrexone, MNTX, Capsule, hard | Norgine International Limited | Coated MNTX is being developed for the prevention of constipation in patients taking opioids for hip and knee replacement surgery for analgesia (pain relief). This drug is as yet unlicensed for use in humans. Studies in subjects have shown no adverse effects of oral doses of MNTX, indicating that oral MNTX is safe and well tolerated in healthy humans at doses of up to 19.2mg/kg. | | | | |
2010-018975-13: EFFICACY OF ROSE HIP IN TREATMENT OF PAIN IN PATIENTS WITH COXARTHROSIS EFFICACIA DELL'ESTRATTO DI ROSA CANINA NEL TRATTAMENTO COMPLEMENTARE DEL DOLORE NEL PAZIENTE AFFETTO DA ARTROSI SEVERA DELL'ANCA |
|
|
| Ongoing | 2 | 200 | Europe | Rose Hip, NA, Coated tablet, Tablet, ALGIX | ISTITUTO ORTOPEDICO RIZZOLI | PATIENTS TO BE IMPLANTED WITH HIP PROSTHESIS SOGGETTI CANDIDATI ALLA PROTESI D'ANCA, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
ChiCTR-TCH-11001421: Effect of Bone Marrow Mesenchymal Stem Cell transplantation in Children with Spinal cord injury without fracture. |
|
|
| Completed | 2 | 20 | | Stem cell transplantation ;Stem cell transplantation | Chinese people's Armed Police Forces; Chinese people's Armed Police Forces, Chinese people's Armed Police Forces | Spinal cord injury without fracture | | | | |
2012-003479-20: Study of treatment of tennis elbow with Botox. Undersökning av behandling av tennisarmbåge med Botox |
|
|
| Ongoing | 2 | 50 | Europe | botulinum toxin, Powder for solution for injection, Dysport | Handkirurgiska kliniken, Universitetssjukhuset Örebro, Handkirurgiska kliniken, Universitetssjukhuset Örebro | Chronic lateral humerus epiconcylitis Kronisk lateral humerusepikondylit., Tennis elbow Tennisarmbåge., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2010-022072-31: A comparison of two different cell types for treating osteoarthritis in the knee. |
|
|
| Ongoing | 2 | 114 | Europe | Autologous chondrocytes, Autologous bone marrow-derived stromal cells, N/A, Suspension for injection | RJAH Orthopaedic Hospital, Arthritis Research UK, Institute of Orthopaedics | osteochondral defects of the knee (early osteoarthritis), early osteoarthritis of the knee, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2012-003160-44: Treatment of arthrosis of the lumbar spine with own stem cells from bonemarrow Behandling af lænderygsgigt med egen stamceller fra knoglemarven. |
|
|
| Ongoing | 2 | 34 | Europe | Mesenchymal stromal cells, Mesenchymal stromal cells, Injection | Orthopaedic Research Laboratory, Århus University Hospital, Orthopaedic Research Laboratory, Århus University Hospital | Moderate intervertebral disc degeneration without radiculopathy Moderat intervertebral diskus degeneration uden udstrålende smerter, Moderate arthrosis/low back pain Moderat lænderygssmerter uden smerter i benene., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
NCT01771510: Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis |
|
|
| Recruiting | 2 | 106 | RoW | Granules, Chung A Won 3g (Eucommiaceae, Psoralea corylifolia, Walnut, Ginger) | Ministry of Health & Welfare, Korea | Diseases of the Musculo-skeletal System and Connective Tissue, Osteoporosis | 11/13 | 11/13 | | |
2013-004140-32: "STUDY TO ASSES A DERIVATIVE HEMATOLOGIC TREATMENT IN ACUTE MUSCLE INJURIES IN ELITE ATHLETES" ?ESTUDIO SOBRE EL USO DE UN TRATAMIENTO CON UN DERIVADO HEMATOLOGICO EN LESIONES MUSCULARES AGUDAS EN DEPORTISTAS DE ALTO RENDIMIENTO" |
|
|
| Ongoing | 2 | 64 | Europe | PRP (OBTENIDO POR PRGF-ENDORET), Solution for injection | Unidad de Cirugia Artroscópica, OSAKIDETZA | Acute Muscle Injury Type 3A-3B (Munich classification) or type II (Classification of Otto Chan), confirmed by radiological diagnosis and clinical agreement. Lesión muscular aguda tipo 3A-3B (clasificación de Munich) o tipo II (Clasificación de Otto Chan), confirmada mediante diagnóstico radiológico, y concordancia clÃnica., Acute Muscle Injury Lesion muscular aguda, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2014-002210-23: Can local botulinum toxin improve swallowing difficulties in persons with msucle disease? |
|
|
| Ongoing | 2 | 15 | Europe | Xeomin, Concentrate and solvent for solution for injection, Xeomin | Rigshospitalet, Rigshospitalet | Oculopharyngesl muscle dystrophy, inclusion body myositis, 2 muscle diseases with pronounced swallowing difficulties, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2013-005402-65: Efficacy and safety of anakinra (antagonist of the interleukin-1 receptor) in the treatment of periarticular inflammation in patients refractory to NSAID and / or steroids Eficacia y seguridad de anakinra (antagonista del receptor de la interleuquina-1) en el tratamiento de la inflamación periarticular en pacientes refractarios a AINES y/o corticoides |
|
|
| Ongoing | 2 | 20 | Europe | Solution for injection in pre-filled syringe, Kineret | Institut de Recerca HSCSP, Swedish Orphan Biovitrum | Inflammation in periarticular structures in patients refractory to NSAIDs and / or corticosteroids. Problemas de inflamación localizados en estructuras periarticulares en pacientes refractarios a AINEs y/o corticoides., Inflammation in periarticular structures in patients refractory to NSAIDs and / or corticosteroids. Problemas de inflamación localizados en estructuras periarticulares en pacientes refractarios a AINEs y/o corticoides., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
| Ongoing | 2 | 105 | Europe | Phylloquinone (vitamin K1), Menatetrenone (MK4) - vitamin K2, Tablet | Guy's and St. Thomas' NHS Foundation Trust, National Osteoporosis Society | Post-menopausal osteoporosis, Osteoporosis occurring after menopause, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2015-000618-23: Effect of pentoxifylline and vitamin E on osteoradionecrosis Effekt av pentoxifyllin och vitamin E på benvävnadsdöd efter strålbehandling |
|
|
| Ongoing | 2 | 40 | Europe | Trental (Pentoxifylline), Tokoferol (Vitamin E), Bonefos (klodronat), NDC:0039-0078-10, NPU26649, PL 00010/0522, Tablet, Capsule, Trental, Tokoferol, Bonefos | Västra Götalandsregionen/NÄL, Västra Götalandsregionen | Osteoradionecrosis Osteoradionekros, Osteoradionecrosis Benvävnadsdöd efter strålbehandling, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2015-000538-31: Application into the joint of opioids in chronic arthritis of the knee joint Injektion von Morphin ins Kniegelenk bei Kniegelenksarthritis |
|
|
| Ongoing | 2 | | Europe | Solution for injection, Suspension for injection, Morphine Hexal, Triam 40 mg Lichtenstein | Charité University medicine Berlin, Bundesministerium für Bildung und Forschung | chronic arthritis of the knee joint effusion as part of spondyloarthritis (Assessments in SpondyloArthritis international Society, ASAS criteria), Rheumatoid Arthritis, RA (according to American Col-lege of Rheumatology, ACR criteria), undifferentiated mono- or oligoarthritis, Osteoarthritis of the knee, OA. Kniegelenksarthritis im Rahmen einer Spondyloarthritis (ASAS Kriterien), Rheumatoid Arthritis (ACR Kriterien) unidfferenzierten Mono- oder Oligoarthritis, Gonarthrose, Gonarthritis as part of spodyloarthritis, rheumatoid arthritis, undifferentiated arthritis of one or more than one joints, osteoarthritis Kniegelenkentzündung im Rahmen einer Spondyloarthrits, rheumatoiden Arthritis, undifferenzierten Arthris eines oder mehrerer Gelenke, Kniegelenksarthrose, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2015-000887-32: Prophylaxis with PENTO before tooth extraction Profylax med PENTO före tandextraktion |
|
|
| Ongoing | 2 | 80 | Europe | Trental (pentoxyfylline), Tokoferol (Vitamin E), NDC: 0039-0078-10, NPU26649, Tablet, Capsule, Trental, Tokoferol | Västra Götalandsregionen/NÄL, Västra Götalandsregionen | Osteoradionecrosis Osteoradionekros, Osteonecrosis after radiation Benvävnadsdöd efter strålbehandling, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2015-001059-63: The Effect of Thiazide Diuretics on Bone Metabolism, Progression ofOsteoporosis and Development of Hyponatremia |
|
|
| Ongoing | 2 | 175 | Europe | Centyl(R) med Kaliumklorid, Coated tablet, Centyl(R) Med Kaliumklorid | Aalborg University, The Obel Family Foundation | The effect of bendroflumethiazide with potassium supplement whenused as an adjuvant to oral bisphosphonates in the treatment of newlydiagnosed osteoporosis among post-menopausal women above 50 yearsof age., Osteoporosis, the lowering of bone mineral density compared to ageaverages, with increased risk of fractures., Body processes [G] - Bones and nerves physological processes [G11] | | | | |
2015-001200-55: Osteoporosis drugs to improve outcome in patients with joint replacement of the hip and knee. |
|
|
| Ongoing | 2 | 1000 | Europe | Zoledronic acid fresenius kabi, Concentrate and solvent for solution for injection/infusion, zoledronic acid fresenius kabi | Region Östergötland, Swedish Research Council | Prosthetic loosening of hip and knee arthroplasty, Joint replacements of the hip and knee becoming loose, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02] | | | | |
2015-003127-62: A Randomized, Placebo-Controlled Study to Evaluate the Effect of Amifampridine in Patients with MuSK Antibody Positive Myasthenia Gravis Studio randomizzato controllato con placebo per valutare l'effetto dell'amifampridina in pazienti affetti da Miastenia Grave Musk positivi |
|
|
| Ongoing | 2 | 20 | Europe | AMIFAMPRIDINA, Tablet, FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE | FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA, Catalyst Pharmaceutical Partners, Inc. | Patients with MuSK Antibody Positive Myasthenia Gravis Pazienti affetti da Miastenia Grave MuSK-positiva, Patients with MuSK Antibody Positive Myasthenia Gravis Pazienti affetti da Miastenia Grave MuSK-positiva, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
|
2015-002622-39: Experimental Study Protocol on Treatment with plasma transfusions in Patients affected by type VI Osteogenesis Imperfecta STUDIO SPERIMENTALE SUL TRATTAMENTO CON TRASFUSIONI DI PLASMA NEI PAZIENTI CON OSTEOGENESI IMPERFETTA TIPO VI |
|
|
| Not yet recruiting | 2 | 10 | Europe | PLASMASAFE, Solution for infusion, PLASMASAFE - SOLUZIONE PER INFUSIONE 1 SACCA DA 200 ML | AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA, AOUI Verona | type VI Osteogenesis Imperfecta OSTEOGENESI IMPERFETTA TIPO VI, Osteogenesis Imperfecta Osteogenesi Imperfetta, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2007-001477-29: A proof-of-concept study of SB-751689 in men and post-menopausal women with a fractured distal radius. |
|
|
| | 2 | 24 | Europe | SB-751689-A, | GlaxoSmithKline R & D Limited, GlaxoSmithKline S.A. | Distal radius fracture | | | | |
2011-000693-57: A Randomized, Placebo-controlled, Double-blind, Two-center Study with Denosumab in Subjects Undergoing Elective Total Knee Replacement Surgery En randomiserad, placebokontrollerad, dubbelblind, tvåcenterstudie med Denosumab för patienter som genomgår planerad total knäproteskirurgi. |
|
|
| Ongoing | 2 | 50 | Europe | Prolia, Prolia | Håkan Ledin (investigator initiated trial), Motala Specialist Care Proxima AB | Patients with idiopathic osteoarthritis of the knee, scheduled for a cemented total knee prosthesis | | | | |
2011-003697-93: Effectiveness of hyperbaric oxygen therapy in the treatment of the open tibial fractures. Open clinical trial, randomized, prospective and controlled. Efectividad de la oxigenoterapia hiperbárica en el tratamiento de las facturas abiertas de tibia. Ensayo clínico abierto, randomizado, prospectivo y controlado. |
|
|
| Ongoing | 2 | 30 | Europe | oxígeno, oxígeno medicinal, oxígeno medicinal | Hospital Universitario de Canarias, IMETISA, Johnson and Johnson | Open tibial fractures Fractura abierta de tibia | | | | |
| Ongoing | 2 | 186 | Europe | ORENCIA 125 mg solution for injection, ORENCIA 125 mg solution for injection | King’s College London, Guy\'s and St. Thomas\' NHS Foundation Trust, Bristol-Myers Squibb | The target population for therapeutic intervention will be subjects who carry serum autoantibodies (antibodies to citrullinated protein antigens – ACPA; rheumatoid factor – RF) and who have joint pains (arthralgia) but no joint swelling. These subjects are deemed to be at highest risk of developing rheumatoid arthritis. | | | | |
2014-000682-50: A feasibility study investigating the clinical effectiveness and cost effectiveness of facet joint injections for low back pain against best usual care. |
|
|
| Ongoing | 2 | 150 | Europe | Levobupivacaine, Triamcinolone acetonide, Levobupivacaine 5mg/ml, Adcortyl Intra-articular/Intradermal Injection 10mg/ml, Levobupivacaine 5mg/ml, Adcortyl Intra-articular/Intradermal Injection 10mg/ml | University Hospitals Coventry and Warwickshire NHS Trust, University of Warwick, Research Support Services, , NIHR HTA | Facet Joint Pain | | | | |
2015-003770-32: A Randomized, Double-Blind, Four Treatment, Four period, Crossover Study, with Placebo, Tizanidine Immediate Release and Diphenhydramine to Study the Effect of Tizanidine Extended Release on Simulated Driving Performance, Cognitive, and Psychomotor Functioning |
|
|
| Ongoing | 2 | 24 | Europe | Tizanidine Extended Release Tablets 12 mg, Zanaflex Tablets 4 mg, GALPHARM ONE A NIGHT NIGHTCALM 50MG TABLETS (Diphenhydramine Hydrochloride), Zanaflex Tablets, GALPHARM ONE A NIGHT NIGHTCALM 50MG TABLETS, Zanaflex Tablets, GALPHARM ONE A NIGHT NIGHTCALM 50MG TABLETS | Sun Pharma Advanced Research Company, Sun Pharma Advanced Research Company | healthy volunteers (acute musculoskeletal pain) | | | | |
2015-000751-25: Zoledronic acid, an osteoporosis drug, in chronic low back pain with specific findings on magnetic resonance imaging: a randomized controlled trial Zoledronihappo, osteoporoosilääke, kroonisessa alaselkäkivussa jossa on spesifisiä löydöksiä magneettikuvauksessa: satunnaistettu kontrolloitu tutkimus |
|
|
| Ongoing | 2 | 250 | Europe | Disodium Zoledronate Tetrahydrate, AXS-02, Tablet | Jaro Karppinen, Axsome Therapeutics Inc. | Chronic low back pain Krooninen alaselkäkipu, Longlasting pain in the lower back Pitkäkestoinen alaselkäkipu, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2015-004227-31: Clinical pilot study to review the impact of perioperative administration of the synthetic cannabinoid nabilone in the context of spinal fusion surgery on the coping with surgery and the pain perception of patients with severely reduced quality of life Klinische Pilotstudie zur Überprüfung des Einflusses einer perioperativen Einnahme des synthetischen Cannabinoids Nabilon im Rahmen stabilisierender Wirbelsäulenoperationen auf die Operationsbewältigung und das Schmerzempfinden von Patienten mit stark reduzierter Lebensqualität |
|
|
| Ongoing | 2 | 36 | Europe | Capsule, Canemes 1 mg Kapseln | OA Dr. Philipp Becker c/o Abteilung für Wirbelsäulenchirurgie, Orthopädisches Spital Speising GmbH, Orthopädisches Spital Speising GmbH, AOP Orphan Pharmaceuticals AG | Spine disease Wirbelsäulenerkrankung, Spine disease Wirbelsäulenerkrankung, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2015-002125-19: A phase 2b Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells inPatients with Knee Osteoarthritis |
|
|
| Ongoing | 2 | 153 | Europe, RoW | Autologous adipose derived stromal, Suspension for injection | CHU MontpellierCentre administratif André Benech,, CHU Montpellier, H2020-PHC-2014-single-stage | Knee Osteoarthritis (mild to moderate), Osteoarthritis, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2015-001820-51: BMC2012, Cell based therapy by implanted bone marrow-derived mononuclear cells (BMC) for bone augmentation of plate-stabilized proximal humeral fractures - a randomized, open, multicentric study - phase IIa BMC2012, Zellbasierte Therapie mit bone marrow-derived mononuclear cells (BMC) zur Knochenaugmentation bei der Osteosynthese proximaler Humerusfrakturen - eine randomisierte, offene, multizentrische Phase IIa Studie |
|
|
| Ongoing | 2 | 94 | Europe | Bone marrow-derived mononuclear cells (BMC), Implantation suspension | Dekan der medizinischen Fakultät, Universitätsklinikum Frankfurt, Goethe-Universität, Hessisches Ministerium für Wissenschaft und Kunst | Investigation of cell based therapy by implanted bone marrow-derived mononuclear cells for bone augmentation on osteosynthesis of proximal humeral fractures Untersuchung der zellbasierten Therapie von bone marrow-derived mononuclear cells zur Knochenaugmentation bei der Osteosynthese proximaler Humerusfrakturen, Subcapatical humeral fractures Subkapitale Humerusfrakturen, Body processes [G] - Bones and nerves physological processes [G11] | | | | |
2016-000943-14: OLT1177 Capsules for the Treatment of Acute Gout Flare OLT1177 Capsules voor de behandeling van acute jichtaanval |
|
|
| Ongoing | 2 | 32 | Europe | Dapansutrile Capsules, OLT1177 Capsules, Capsule, hard | Olatec Therapeutics LLC, Olatec Therapeutics LLC | Acute gout flare Acute jichtaanval, Gout Flare Jichtaanval, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2014-002118-21: Zoledronate against fractures in children with cerebral palsy Zoledronat mod knoglebrud hos børn med spastisk lammelse |
|
|
| Ongoing | 2 | 80 | Europe | zoledronate, zol, Concentrate for solution for injection/infusion, Zoledronsyre â€Fresenius Kabi†| Randers Regional Hospital, The Research Foundation of The Central Denmark Region, Randers Regional Hospital, Aarhus University, Dagmar Marshalls Foundation, Riisfort Foundation, Linex Foundation | cerebral palsy, osteopenia, fracture cerebral parese, osteopeni, fraktur, physical impairment, low bone density, broken bone spastisk lammelse, lav knogletæthed, knoglebrud, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2016-002611-18: Lidocaine/diclofenac epolamine patch (GRT7019) Phase II proof-of-concept trial in patients with chronic pain due to knee osteoarthritis. |
|
|
| Ongoing | 2 | 300 | Europe | Lidocaine 700 mg / Diclofenac epolamine 182 mg Patch, GRT7019, Medicated plaster, Modified-release tablet, Gastro-resistant tablet, Versatis 5% medicated plaster, Diclo 75 SL - 1A Pharma, Pantoprazol-ratiopharm 20 mg | Grünenthal GmbH, Grünenthal GmbH | osteoarthritis, osteoarthritis, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2017-001022-17: Vitamin D supplementation to breast cancer survivors with joint pain on treatment with an aromatase inhibitor to reduce their risk for breast cancer relapse. The patients is its own control and pain is measured before and after 12 weeks of vitamin D supplementation |
|
|
| Ongoing | 2 | 50 | Europe | Oral drops, solution, Detremin | Breastcentre, Capio St Gorans Hospital, ALF Funding | Breast cancer survivors on adjuvant treatment with an aromatase inhibitor having joint pain, Breast cancer survivors with joint pain on treatment with an aromatase inhibitor to reduce their risk for breast cancer relapse, Diseases [C] - Cancer [C04] | | | | |
2016-003773-17: Comparison of intranasally given drug dexmedetomidine withN2O (=laughing gas) for sedation for small procedures in children'semergency department. Smärtlindrande och lugnande medicinering inför behandlingen på barnakuten-Dexmedetomidin en medicin som kan ges i näsan jämförs med lustgas. |
|
|
| Ongoing | 2 | 156 | Europe | Infusion, Inhalation vapour, Dexdor, Niontix | Karolinska University Hospital, Karolinska University Hospital | sedation for emergency procedures, sedation for procedures (for example fracture reduction, burn dressing)in the emergency department, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03] | | | | |
2016-002651-25: A Study of Prednisolone in Patients with Early (within 3 years of onset) Diffuse Cutaneous Scleroderma (Systemic Sclerosis) |
|
|
| Ongoing | 2 | 72 | Europe | Prednisolone 5mg Gastro-resistant Tablets, Capsule, Prednisolone 5mg Gastro-resistant Tablets | Research Governance and Integrity, University of Manchester, Arthritis Research UK, NIHR CRN: Greater Manchester | Early diffuse cutaneous systemic sclerosis, Early (within 3 years of onset) diffuse cutaneous scleroderma, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2016-000754-35: The Effect of Denosumab on Pain and Bone Marrow Lesions in Symptomatic Knee Osteo-arthritis : A Randomised Double Blind Placebo Controlled Clinical Trial |
|
|
| Ongoing | 2 | 167 | Europe | Prolia, Solution for injection, Prolia | The University of Manchester, Arthritis Research UK, AMGEN | Knee osteoarthritis, Knee joint damage due to wear and tear, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2017-002129-39: Comparision of two treatments, MR2 versus GPS III®in patients with rotulian tendinopathy Comparación de dos tratamientos, el M2R y el KIT GPS III® en pacientes con tendinopatÃa rotuliana |
|
|
| Ongoing | 2 | 40 | Europe | M2R. Terapia sérica autóloga con células de la serie blanca, PRP. Plasma Rico en Plaquetas, Blood fraction modifier | XCELL Medical Solutions, XCELL Medical Solutions SL | Patients with Rotulian Tendinopathy Pacientes con tendinopatÃa Rotuliana, Patients with Rotulian Tendinopathy Pacientes con tendinopatÃa Rotuliana, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2017-001327-45: A pilot study of Ceftobiprole diffusion in bone and joint, in patients with BIJ( bone and joint infection) undergoing hip or knee replacement. Etude pilote de dosage du Ceftobiprole dans les infections ostéo-articulaires chez des patients infectés programmés pour une chirurgie de remplacement de prothèse de hanche ou de genou. |
|
|
| Ongoing | 2 | 10 | Europe | Ceftobiprole, Powder for concentrate for solution for infusion, MABELIO | Hospices Civils de Lyon, Basilea Pharmaceutica International AG | Bone or joint Infection Infection ostéo-articulaire, Bone or joint Infection Infection ostéo-articulaire, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
2016-004755-75: Intra articular injection of microfat and platelet-rich plasma in the treatment of knee osteoarthritis : a pilot study |
|
|
| Not yet recruiting | 2 | 30 | Europe | autologous Microfat, Injection | Clinique Juge, Clinique Juge | knee osteoarthritis, knee osteoarthritis, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2016-002085-31: Determining the immunological and pain reducing effects of serial radon balneology in patients with musculoskeletal disorders. Bestimmung der immunologischen und Schmerz lindernden Wirkung von seriellen Radonbädern bei Patienten mit muskuloskelettalen Beschwerden. |
|
|
| Ongoing | 2 | 100 | Europe | Radon, none, Bath additive | Kurort Forschungsverein Bad Steben e.V., Landesamt für Gesundheit und Lebensmittelsicherheit Bayern (LGL), Kurort Forschungsverein Bad Steben e.V., Bayerisches Staatsbad Bad Steben GmbH, Market community Bad Steben | Chronic degenerative spine and/or joint disorders with pain perception of at least 1 year and pain intensity on visual analogue scale ≥4 Chronisch degenerative Wirbelsäulen- und Gelenkbeschwerden mit einer Schmerzdauer von mindestens 1 Jahr und einer Schmerzintensität nach Visueller-Analog-Skala ≥4, Chronic degenerative spine and/or joint disorders with pain perception of at least 1 year and pain intensity on visual analogue scale ≥4 Chronisch degenerative Wirbelsäulen- und Gelenkbeschwerden mit einer Schmerzdauer von mindestens 1 Jahr und einer Schmerzintensität nach Visueller-Analog-Skala ≥4, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2017-004049-26: Lopain (MTX-071 / resiniferatoxin) Study to determine the safety and clinical effects of intra-articular injections of low doses of Lopain (MTX-071) in patients with chronic osteoarthritic knee joint pain |
|
|
| Ongoing | 2 | 24 | Europe | Lopain, MTX-071, Concentrate for solution for injection | Mestex, Mestex AG | chronic osteoarthritic knee-joint pain, Pain due to degenerative lesions of the knee joint, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2017-000860-14: Blinded study on safety, tolerability and lumbar fusion efficacy of a single dose of Osteogrow (which comprises a protein called BMP6 mixed with the patients own blood to form a clot) in adult patients treated by spinal fusion (posterolateral lumbar interbody fusion, PLIF) for degenerative disc disease |
|
|
| Ongoing | 2 | 192 | Europe | Osteogrow, rhBMP6, Powder and solvent for implantation paste | Genera Research Ltd, EU Commision, H2020 work programme | Lumbar spine single segment destabilization caused by degenerative disc disease, Chronic lower back pain, Body processes [G] - Bones and nerves physological processes [G11] | | | | |
2017-003574-13: Medical cannabis for the treatment of pain in patients with hand osteoarthritis and psoriatic arthritis. Medicinsk cannabis til behandling af smerter ved slidgigt i hænderne eller psoriasis gigt. |
|
|
| Ongoing | 2 | 160 | Europe | Cannabidiol, CBD, Tablet | Aalborg university hospital dept. of rheumatology, Region Nordjyllands Sundhedsvidenskabelige Forskningsfond, Forskningenshus uddannelse og innovation, Aalborg University Hospital dept. of reumatology, Aalborg University | Psoriatic ArthritisHand Osteoarthritis Psoriasis gigtHånd artrose, Psoriatic arthritisHand osteoarthritis Psoriasis gigtSlidgigt i hænderne, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2016-003594-17: Effects of a single denosumab injection on reduction of total contact cast treatment and consolidation of bonefractures caused by acute Charcotfoot in patients with diabetes mellitus (CHARCOT study) Effects van denosumab injectie on duur gipsbehandeling en snelheid van voetbotbreuken als gevolg van acute charcot voet bij patiënten met diabetes mellitus (CHARCOT study) |
|
|
| Ongoing | 2 | 30 | Europe | denosumab, SUB29173, Injection | AMC, AMC | charcot foot charcot voet, charcot foot charcot voet, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2018-000391-15: Multicentric, prospective open-label study to assess the efficacy and safety of Tocilizumab in subjects with refractory myositis Studio multicentrico, prospettico in aperto per valutare l’efficacia e la sicurezza di Tocilizumab in soggetti con miosite refrattaria |
|
|
| Not yet recruiting | 2 | 16 | Europe | RoActemra 162 mg soluzione iniettabile in siringa preriempita, NA, Solution for injection, RoActemra 162 mg soluzione iniettabile in siringa preriempita | Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, AIFA (Agenzia Italiana del Farmaco) | Myositis (dermatomyositis [DM] or polymyositis [PM]) Miositi: Dermatomiosite (DM) e Polimiosite (PM), Chronic inflammatory disorders of striated muscle with variable involvement of internal organs Patologie infiammatorie croniche del muscolo striato con variabile interessamento degli organi interni, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2016-004250-15: Establishing a dose of hormone supplementation in trauma patients that will increase hormone levels in the body |
|
|
| Not yet recruiting | 2 | 270 | Europe | Dehydroepiandrosterone filmcoat tablet, Dehydroepiandrosterone sublingual tablets, Coated tablet, Sublingual tablet | University Hospitals Birmingham, AO-UK, Queen Elizabeth Hospital Birmingham Charity | DHEA depletion in trauma and hip fracture patients., Low hormone levels in patients who have been severely injured in accidents or have a hip fracture., Body processes [G] - Metabolic Phenomena [G03] | | | | |
2018-000886-35: Evaluation of safety, feasibility and preliminary efficacy of MSCs from third party donors in the treatment of patients with osteonecrosis of the femoral head after allogeneic Stem Cell Transplantation Evaluación de la seguridad, viabilidad y eficacia preliminar de CMMs de donantes, en el tratamiento de pacientes con osteonecrosis de la cabeza femoral tras un trasplante alogénico de Células Madre |
|
|
| Ongoing | 2 | 7 | Europe | Cultured mesenchymal stem cells from bone marrow isolation, BM-MSCs, Suspension for injection | Enrique Gomez-Barrena, Instituto Carlos III | Osteonecrosis of the Femoral Head Osteonecrosis de la cabeza femoral, Osteonecrosis of the Femoral Head Osteonecrosis de la cabeza femoral, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2017-004226-15: Can-ArtEffect and safety of using Canabis derivatives for the treatment of pain in patients with inflammatory Arthritis, such as reumatoid arthritis and ankylosing spondylitis, the latter being a type of arthritis that causes a long term inflammation of the joints of the spine. A randomized, double blinded, placebo controlled trial, i.e. in this drug trial, a control group is given a placebo while another group is given the Cannabis derivative being studied. Can-ArtEffekt og sikkerhed ved anvendelse af Canabis-derivater til behandling af smerte hos patienter med inflammatorisk arthritis, såsom rheumatoid arthritis og ankyloserende spondylitis (sidstnævnte er en type arthritis, der forårsager langvarig betændelse i rygsøjlen og bækkenet).En randomiseret, dobbeltblindet, placebokontrolleret forsøg, dvs. i denne lægemiddelforsøg, gives en kontrolgruppe en placebo, mens en anden gruppe får substansen, der undersøges, dvs. Cannabis derivatet. |
|
|
| Ongoing | 2 | 180 | Europe | Cannabidiol tablet 10 mg, Dronabinol capsule 2.5. mg, Tablet, Capsule | King Christian 10th Hospital for Rheumatology, The Danish Rheumatism Association, The Region of Southern Denmark | Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS), RA and AS are autoimmune diseases. In RA the immune system attacks the membranes lining the joints, typically initially in small joints. AS affects the joints of the spine and the pelvic girdle., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2018-003537-15: Comparison of different dosing of Tranexamic Acid during major orthopedic surgery. |
|
|
| Ongoing | 2 | 180 | Europe | Solution for injection, Cyklokapron 100 mg/ml Injektionslösung | Medical University Vienna, Medical University Vienna | Blood loss in patients undergoing elective total hip or knee arthroplasty., Blood loss in patients undergoing planned total hip or knee replacement surgery., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04] | | | | |
2018-000818-37: The pain reduction effects of different doses of Lopain (MTX-071) relative to placebo are evaluated in patients with chronic osteoarthritic knee joint pain. Porovnávanie efektu zníženia bolesti pri rôznych dávkach Lopainu (MTX-071) oproti placebu hodnoteného u pacientov s chronickou osteoartritídou kolenného kĺbu. |
|
|
| Ongoing | 2 | 60 | Europe, RoW | Lopain, MTX-071, Concentrate for solution for injection | Mestex AG, Mestex AG | chronic osteoarthritic knee joint pain, pain due to degenerative lesions of the knee joint, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2018-001360-39: Randomized Controlled Trial comparing two groups of Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity: the first one receiving Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab after surgery, and the second one receiving Radiotherapy and surgery, aiming to assess the safety and efficacy profile of Pembrolizumab Studio clinico controllato randomizzato che confronta due gruppi di pazienti affetti da sarcoma dei tessuti molli in fase localizzata, ad alto rischio: il primo riceve Pembrolizumab neoadiuvante abbinato a radioterapia e Pembrolizumab adiuvante dopo chirurgia, mentre il secondo riceve il trattamento standard: radioterapia preoperatoria e chirurgia. Lo scopo è di valutare sicurezza ed efficacia di Pembrolizumab. |
|
|
| Not yet recruiting | 2 | 110 | Europe | Pembrolizumab, [MK-3475], Solution for infusion | SARC, SARC, Merck Sharp & Dohme Corp. | This trial investigates whether neoadjuvant radiotherapy combined with pembrolizumab followed by surgical resection and adjuvant pembrolizumab improves disease-free survival for patients with high-risk soft tissue sarcoma of the extremity (undifferentiated pleomorphic sarcoma or dedifferentiated/pleomorphic liposarcoma, tumor size > 5 cm, grade 2 or 3 out of 3) compared to radiotherapy alone followed by surgical resection Lo studio indaga se la radioterapia neoadiuvante abbinata a pembrolizumab seguita da exeresi chirurgica e in seguito da pembrolizumab adiuvante migliori la sopravvivenza libera da malattia dei pazienti con sarcoma dei tessuti molli degli arti ad alto rischio (sarcoma pleomorfo indifferenziato o liposarcoma pleomorfo/dedifferenziato, dimensioni > 5 cm, grado 2 o 3 su 3) rispetto a sola radioterapia seguita da chirurgia., This trial investigates whether pre and post surgery pembrolizumab treatment improves disease-free survival for patients with high-risk soft tissue sarcoma of extremity vs RT alone followed by surgery Indaga se il trattamento con pembrolizumab pre e post chirurgia migliora sopravvivenza libera da malattia dei pazienti con sarcoma tessuti molli degli arti ad alto rischio rispetto a RT più chirurgia., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2018-004277-27: A study to test the safety and effectiveness of MT1621 in people who are deficient in an enzyme located in the mitochondrial called tk2. Estudio para comprobar la seguridad y eficacia de MT1621 en personas con deficiencia de una enzima mitocondrial denominada tk2 |
|
|
| Not yet recruiting | 2 | 38 | Europe | deoxycytidine and deoxythymidine, MT1621, Powder for oral solution | Modis Therapeutics, Inc., Modis Therapeutics, Inc. | Thymidine kinase 2 deficiency Deficiencia de timidina cinasa 2, Genetic disease in which patients' cells have reduced amounts of mitochondrial DNA leading to progressive muscle weakness. Enfermedad genética en la cual las células del paciente contienen cantidades reducidas de DNA mitocondrial que conducen a una debilidad muscular progresiva., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2019-000305-79: An extension study to the A083-02 and A083-03 studies that evaluate the long-term effect of the ACE-083 investigational product in patients with Facioscapulohumeral Muscular Dystrophy (FSHD) previously participated in study A083-02 and also in patients with Charcot-Marie Tooth (CMT) disease type 1 and X who previously participated in study A083-03. Estudio de extensión de los estudios A083-02 y A083-03 que evalua los efectos a largo plazo del medicamento en investigación ACE-083 en pacientes con distrofia muscular facioescapulohumeral (DFEH) que han participado anteriormente en el estudio A083-02 y en pacientes con enfermedad de Charcot-Marie-Tooth (CMT) de tipos 1 y X que han participado anteriormente en el estudio A083-03 |
|
|
| Not yet recruiting | 2 | 150 | Europe | ACE-083, ACE-083, Lyophilisate for solution for injection | Acceleron Pharma Inc., Acceleron Pharma Inc. | Facioscapulohumeral Muscular Dystrophy Distrofia muscular facioescapulohumeral, Muscle disease characterized by muscle weakness and wasting (atrophy). The most affected muscles are the face (facio-), around the shoulder blades (scapulo-), and in the upper arms (humeral). Enfermedad muscular caracterizada por debilidad y desgastemuscular(atrofia).Músculos más afectados: cara(facio-),alrededor de losomóplatos (escapulo-),y parte superior de los brazos (humeral)., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2019-002749-40: Efficacy of intradiscal injection of cells from the bone marrow in subjects with chronic back pain, caused by a degenerative disease affecting the vertebral idisc,which does not respond to traditional therapy. Efficacia dell'iniezione intradiscale di cellule provenienti dal midollo osseo in soggetti con mal di schiena cronico, causato da una malattia degenerativa che colpisce il disco vertebrale, che non risponde alla terapia tradizionale. |
|
|
| Ongoing | 2 | 52 | Europe | Cellule staminali mesenchimali/stromali autologhe isolate da midollo osseo, [auto BM-MSC], Suspension for injection | UNIVERSITÀ CAMPUS BIO-MEDICO DI ROMA, Ministero della Salute (Bando Ricerca Finalizzata) | Symptomatic chronic low back pain due to a degenerative disease of the intervertebral disc Lombalgia cronica sintomatica dovuta a malattia degenerativa del disco intervertebrale, Low back pain is the chronic pain of the lower back due to the constant deterioration of the area between the two disks of the spine. La Lombalgia è il dolore cronico della parte bassa della schiena dovuta al costante deterioramento della zona presente tra i due dischi della colonna vertebrale., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2018-004047-23: A study to evaluate if the patients own stem cells combined with biomaterial will be effective and safe in bone healing in patients with fractures in the leg or arm, that did not heal with conventional treatment. En studie for å undersøke om pasientens egne stamceller i kombinasjon med et biomaterial vil være en trygg og effektiv behandling av brudd i arm eller fot der vanlig behandling ikke har ført til tilheling.(Norsk språk, var ikke som alternativ) |
|
|
| Not yet recruiting | 2 | 10 | Europe | Mesenchymal stem cells and microporous Bi-phasic calcium phosphate (MBCP+), Behandling, Ortho, Granules | University of Bergen, University of Bergen, The research counsil of Norway, Biomatlante | Diaphyseal and/or metaphysodiaphyseal fractures (femur, tibia, humerus) status delayed union (after 3 months) treated by standard care procedures, Fractures in arm or leg that have not healed after 3 months with conventional treatment. Brudd i underarm eller legg som ikke vil gro normalt etter forventet tid., Diseases [C] - Injuries, poisonings, and occupational diseases [C21] | | | | |
2019-003324-20: A clinical trial to judge the safety, tolerability and effects on abnormal bone formation of reseach medication AZD 0530 (sarcatinib) in patients with FOP Een onderzoek ter beoordeling van de veiligheid, verdraagbaarheid en effecten op abnormale botvorming van het onderzoeksgeneesmiddel AZD0530 (saracatinib) bij patiënten met FOP |
|
|
| Not yet recruiting | 2 | 20 | Europe | Saracatinib, AZD0530, Tablet | VU University Medical Center, Innovative Medicines Initiative EU, AstraZeneca | Fibrodyplasia Ossificans Progressiva (FOP), Genetic condition which causes abnormal formation of bone at abnormal locations such as in the muscles, tendons and ligaments., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2015-005285-38: ARCADIA: Phase II proof of concept study of Abatacept (Orencia) in individuals who aRe Considered At risk of Developing Inflammatory Arthritis |
|
|
| Not yet recruiting | 2 | 58 | Europe | Orencia, Solution for injection in pre-filled syringe, Orencia | The University of Leeds, Bristol Myers Squibb | Inflammatory arthritis, Inflammatory arthritis, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2019-004515-31: SB-061 for the Treatment of Symptomatic Osteoarthritis of the Knee |
|
|
| Ongoing | 2 | 278 | Europe | SB-061, Lyophilisate for solution for injection | Nordic Bioscience Clinical Development A/S, Nordic Bioscience Clinical Development A/S | Osteoarthritis of the Knee, Osteoarthritis of the Knee, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2019-002963-92: Safety, tolerability and efficacy of multiple intra-articular injections of LRX712 in patients with knee osteoarthritis. |
|
|
| Not yet recruiting | 2 | 45 | Europe | LRX712, Suspension for injection | Novartis Pharma AG, Novartis Pharma AG | Cartilage injuries, Cartilage injuries, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2019-002444-24: Clinical trial of a single dose of treprostinil injected as a depot under the skin to investigate the effect on the digital blood flow and safety in patients with Raynaud’s Phenomenon due to Systemic Sclerosis |
|
|
| Not yet recruiting | 2 | 12 | Europe | CAM2043, CAM2043, Prolonged-release solution for injection | Camurus AB, Camurus AB | Raynaud’s phenomenon secondary to systemic sclerosis, Raynaud’s phenomenon due to systemic sclerosis, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2018-004254-22: Efficacy of Tofacitinib in Reduction of Spinal Inflammation Detected on MRI in Patients with Psoriatic ArthritiS |
|
|
| Not yet recruiting | 2 | 80 | Europe | Film-coated tablet, Xeljanz 5 mg tablets | Charite University, Pfizer Pharma GmbH, unrestricted grant | Psoriatic Arthritis with axial (spinal) involvement, Psoriatic Arthritis with Inflammation at the spine or sacroiliacal joints, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2019-004704-35: Jaw muscle pain relief following local injection with Botox. A randomized double-blind controlled multicenter pilot study |
|
|
| Not yet recruiting | 2 | 48 | Europe | Powder for solution for injection, Botox 100 Allergan-units | Region Örebro, Region Örebro, Centrum för specialisttandvård, Region Västmanland, Hälso- och sjukvårdsförvaltningen | Myalgia of jaw muscle, Jaw muscle pain, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2019-003868-42: A trial of the drug Baricitinib in the treatment of patients with muscle inflammatory conditions. |
|
|
| Not yet recruiting | 2 | 25 | Europe | Olumiant, Tablet, Olumiant | University of Manchester, Eli Lilly and Company | Idiopathic Inflammatory Myopathy (IIM), Inflammation of muscle tissue which can lead to profound weakness, fatigue and disability, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2019-004426-24: Deflazacort TREATment in LMNA related congenital muscular dystrophy: study of clinical effectiveness and search for reliable biomarkers. Deflazacort TRATTAMENTO nella distrofia muscolare congenita correlata a LMNA: studio dell'efficacia clinica e ricerca di biomarcatori affidabili |
|
|
| Not yet recruiting | 2 | 20 | Europe | Deflazacort, Lucen, [Deflazacort], [-], Oral drops, solution, Gastro-resistant granules, Lucen | AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, AIFA - Italian Medicines Agency | Congenital Muscolar distrophy LMNA related Distrofia muscolare congenita correlata a LMNA ( L-CMD), Congenital muscolar distrophy coused by lamina gene mutation distrofia muscolare congenita causata da mutazione del gene lamina, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2020-002955-40: analgesic effect of orally administrated nefopam Évaluation de l’efficacité analgésique du nefopam en administration orale |
|
|
| Ongoing | 2 | 40 | Europe | Solution for injection, NEFOPAM MEDISOL 20 mg/2 ml, solution injectable | Hospices Civils de Lyon, Hospices Civils de Lyon, APICIL | Major patients who have a surgery in the orthopedic surgery department of the Croix Rousse hospital for a total knee replacement. Patients majeurs devant être opérés d'une chirurgie de prothèse totale de genou dans le service d’orthopédie de l’hôpital de la Croix-Rousse ., Total knee replacement surgery. Chirurgie de prothèse totale de genou., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03] | | | | |
2020-002127-10: Evaluation of pain after intra-articular injections of botulinum toxin in carpometacarpal osteoarthritis of the thumb Évaluation de la douleur après injections intra-articulaires de toxine botulique dans l'arthrose carpométacarpienne du pouce |
|
|
| Not yet recruiting | 2 | 60 | Europe | XEOMIN 50, Injection, XEOMIN 50 | CHU de Nice, CHU de Nice | Rhizarthrosis Rhizarthrose, Rhizarthrosis Rhizarthrose, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2020-003169-20: Efficacy of dalbavancin during osteo-articular infections associated with hip and knee prostheses Efficacité de la dalbavancine au cours des infections ostéo-articulaires associées aux prothèses (IOAP) de hanche et de genou |
|
|
| Not yet recruiting | 2 | 43 | Europe | Powder for solution for infusion, XYDALBA | CHU de Nice, CHU de Nice | Osteo-articular infections Infections ostéo-articulaires associées aux prothèses, Osteo-articular infections Infections ostéo-articulaires associées aux prothèses, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2019-002394-59: Medical Cannabis for Fibromyalgia Medicinsk Cannabis for Fibromyalgi |
|
|
| Not yet recruiting | 2 | 200 | Europe | Cannabidiol tablet 10 mg, None | The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Oak Fondation, The Danish Rheumatism Association, Bispebjerg and Frederiksberg Internal research Grant, Erna Hamilton Foundation, Aase and Ejnar Danielsens foundation, Nordic Cannabis Research, Linnea Switzerland | Fibromyalgia Fibromyalgi, Chronic Widespread Pain Kroniske generaliserede muskelsmerter, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
MSC, NCT04499105: Effectiveness and Safety of Mesenchymal Stem Cell () Implantation on Degenerative Discus Disease Patients |
|
|
| Recruiting | 2 | 10 | RoW | Mesenchymal Stem Cell + NaCl 0,9% 2ml | Ahmad Jabir Rahyussalim | Degenerative Disc Disease, Low Back Pain, Disc Degeneration | 12/20 | 12/20 | | |
2019-000809-71: Saline injections versus Education and Exercise in knee osteoarthritis Sammenligning af saltvandsinjektioner i knæleddet med et undervisnings og træningsprogram til behandling af symptomer ved knæartrose: Et randomiseret åben-label, kontrolleret, evidensbaseret forsøg. |
|
|
| Not yet recruiting | 2 | 200 | Europe | Solution for injection, Natriumklorid isotonisk "SAD" | The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, the Oak Foundation, Lundbeckfonden, Danish Association of Physiotherapists | Knee osteoarthritis Knæartrose, Knee osteoarthritis Knæartrose (slidgigt), Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
NCT04557878: Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction |
|
|
| Completed | 2 | 24 | RoW | Hypertonic Dextrose Solution, Liquid Phase Concentrated Growth Factor (LPCGFs) | Nourhan M.Aly, Alexandria University | Temporomandibular Joint Disorders, Temporomandibular Disorder | 04/21 | 06/21 | | |
2020-000249-14: A placebo-controlled, double-blinded, randomized, trial using a combination of apocynin and paeonol (APPA) for the treatment of knee osteoarthritis |
|
|
| Not yet recruiting | 2 | 150 | Europe | APPA, Capsule | AKL Research and Development Ltd, AKL Research and Development Ltd | Radiographic and symptomatic knee osteoarthritis in either one or both knees, Radiographic and symptomatic knee osteoarthritis in either one or both knees, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
ACTRN12615000958583: Is antibiotic treatment effective in the management of chronic low back pain? A clinical trial. |
|
|
| Completed | 2 | 170 | | | Monash University, National Health and Medical Research Council | Low back pain with lumbar disc herniation | | | | |
2018-002081-39: A clinical trial to evaluate the efficacy and safety of clodronate at different dosages, after intra-articular injections to patients affected by knee osteoarthritis. |
|
|
| Ongoing | 2 | 660 | Europe, RoW | Clodronate disodium, [NA], Solution for injection | Abiogen Pharma S.p.A., ABIOGEN PHARMA S.P.A., Abiogen Pharma S.p.A. | knee osteoarthritis, degenerative disease of the knee joint, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2019-004108-37: A study to determine how effective and safe the drug CC-99677 is for patients with active Ankylosing Spondylitis |
|
|
| Not yet recruiting | 2 | 256 | Europe, RoW | CC-99677 60mg Capsule, CC-99677 30mg Capsule, Capsule | Celgene Corporation, Celgene Corporation | Ankylosing Spondylitis, Ankylosing spondylitis (AS) is a long-term condition in which the spine and other areas of the body become inflamed., Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2020-006104-17: Study of efficacy, safety and tolerability of DFV890 in patients with knee osteoarthritis |
|
|
| Ongoing | 2 | 108 | Europe | DFV890, DFV890, Film-coated tablet | Novartis Pharma AG, Novartis Farmacéutica S.A., Novartis Pharma AG | knee osteoarthritis, knee osteoarthritis, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
NCT04609748: Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint. |
|
|
| Recruiting | 2 | 30 | Europe | Cannabidiol Oil, Nimesulide | Pomeranian Medical University Szczecin | Temporomandibular Joint Disorders, Temporomandibular Joint Dysfunction Syndrome, Temporomandibular Joint Pain | 07/21 | 12/21 | | |
2020-004568-25: Belimumab in patients with Antiphospholipid Syndrome Belimumab in pazienti con Sindrome da Anticorpi Antifosfolipidi |
|
|
| Not yet recruiting | 2 | 23 | Europe | Belimumab, [041381029], Powder and solvent for concentrate for solution for infusion, Benlysta | DIPARTIMENTO DI SCIENZE CLINICHE E BIOLOGICHE (UNITO), GSK | APS APS, Antiphospholipid Syndrome Sindrome da Anticorpi Antifosfolipidi, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
NCT05189002: A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement |
|
|
| Active, not recruiting | 2 | 240 | RoW | Dimolegin 40 mg, DD217, Dimolegin 60 mg, Fragmin, Dalteparin sodium | PharmaDiall Ltd. | Venous Thromboembolism | 08/21 | 12/22 | | |
2021-000859-39: A Phase 2 Study Evaluating the Safety, Efficacy and Pharmacokinetics of Single Dose EP-104IAR for 24 Weeks in Patients with Osteoarthritis of the Knee |
|
|
| Not yet recruiting | 2 | 300 | Europe | EP-104IAR, Powder and solution for suspension for injection | Eupraxia Pharmaceuticals Inc., Eupraxia Pharmaceuticals Inc. | Osteoarthritis of the knee, Knee osteoarthritis, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
NCT04593849: Therapeutic Effects of Traditional Chinese Medicine in Topical Use on Upper Extremities Fracture |
|
|
| Recruiting | 2 | 24 | RoW | Ru-Yih-Jin- Huang-Saan(RYJHS), Wan-Yin-Gao-Jia-Jean-Wey(WYGJJW), placebo ( topical agent without therapeutic effects) | YUAN-CHIEH YEH | Bone Fractures, Traditional Chinese Medicine, Chinese Herbal Medicine | 09/21 | 09/22 | | |
NCT05407753: Effect of Exogenous Ketosis During Ultra-endurance Exercise |
|
|
| Active, not recruiting | 2 | 24 | Europe | Ketone ester, Placebo | KU Leuven | Exercise, Ultra-endurance Running, Ketosis, Skeletal Muscle, Cognitive Function | 10/21 | 12/22 | | |
2021-005401-28: Effects of the combination of magnesium bisphosphonates versus bisphosphonates alone on bone remodeling: |
|
|
| Not yet recruiting | 2 | 48 | Europe | MAG 2 100mg, Tablet, MAG 2 100 mg | University Hospital of Clermont-Ferrand, Appel d'offre interne 2021 (institutional source) | postmenopausal osteoporosis, osteoporosis, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2021-001855-15: A study to evaluate long-term Infigratinib in children with Achondroplasia Un estudio para evaluar Infigratinib a largo plazo en niños con acondroplasia |
|
|
| Not yet recruiting | 2 | 280 | Europe | Infigratinib, BGJ398 (also known as BBP-831), Tablet | QED Therapeutics, Inc., QED Therapeutics, Inc. | Achondroplasia in Children Acondroplasia en niños, Disproportionate short stature with rhizomelia (shortened proximal limbs). Estatura desproporcionádamente corta con rizomelia (miembros proximales acortados), Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2021-001629-38: Phase 2 trial, conducted in more than one site, in which no one knows the treatment assigned to the patient to evaluate the effect against pain and the safety of the study drug, DFL24412, respect a control drug (Ketoprofen Lysine Salt), in patient with chronic low back pain |
|
|
| Not yet recruiting | 2 | 150 | Europe | Co-crystal of ketoprofen, lysine and gabapentin, Ketoprofen Lysine Salt, DFL24412, KLS, Capsule, hard | Dompè Farmaceutici S.p.A., DOMPé FARMACEUTICI S.P.A., Dompè Farmaceutici S.p.A. | Chronic Low Back Pain Lumbalgia crónica (LC), Chronic Low Back Pain Lumbalgia crónica, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |